Investor Announcements - 2019
|
| ||
EKF Diagnostics Holdings plc announces its final results for the year ended 31 December 2018. | ||
| ||
EKF announces that it will release its preliminary results for the year ended 31 December 2018 on Wednesday 13 March 2019. | ||
| ||
EKF Diagnostics announces that its Quo-Test analyser has received US Food and Drug Administration 510(k) clearance for professional use in a clinical laboratory setting. | ||
| ||
EKF announces the full launch of the McKesson Consult® Hb analyzer in the US in February. | ||
| ||
EKF Diagnostics provides shareholders with the following update on current trading. | ||
| ||||
Newsletter
Keep up to date with all our activities, events, exhibitions, promotions, investor news & more.